Evidence map›Paper›PMID 25391136›Full record

ArticlePloS one2014

Analysis of non-typeable Haemophilous influenzae VapC1 mutations reveals structural features required for toxicity and flexibility in the active site.

Brooke Hamilton, Alexander Manzella, Karyn Schmidt, Victoria DiMarco, J Scott Butler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Brooke HamiltonDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America.
Alexander ManzellaDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America.
Karyn SchmidtDepartment of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, United States of America.
Victoria DiMarcoDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America.
J Scott ButlerDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America; Department of Biochemistry and Biophysics, University of Rochester Medical Center, Rochester, New York, United States of America; Center for RNA Biology, University of Rochester Medical Center, Rochester, New York, United States of America.
University of Rochester Medical Center · US

Funding

Novel whole cell HTS for inhibitors of bacterial toxin-antitoxin interactionR01GM099731 · NIGMS · UNIVERSITY OF ROCHESTER · PI BUTLER, JAMES SCOTT · 2012 to 2014
$856k
NIGMS NIH HHS GM-099731NIGMS NIH HHS R01 GM099731
6 · The paper itself

Abstract

Bacteria have evolved mechanisms that allow them to survive in the face of a variety of stresses including nutrient deprivation, antibiotic challenge and engulfment by predator cells. A switch to dormancy represents one strategy that reduces energy utilization and can render cells resistant to compounds that kill growing bacteria. These persister cells pose a problem during treatment of infections with antibiotics, and dormancy mechanisms may contribute to latent infections. Many bacteria encode toxin-antitoxin (TA) gene pairs that play an important role in dormancy and the formation of persisters. VapBC gene pairs comprise the largest of the Type II TA systems in bacteria and they produce a VapC ribonuclease toxin whose activity is inhibited by the VapB antitoxin. Despite the importance of VapBC TA pairs in dormancy and persister formation, little information exists on the structural features of VapC proteins required for their toxic function in vivo. Studies reported here identified 17 single mutations that disrupt the function of VapC1 from non-typeable H. influenzae in vivo. 3-D modeling suggests that side chains affected by many of these mutations sit near the active site of the toxin protein. Phylogenetic comparisons and secondary mutagenesis indicate that VapC1 toxicity requires an alternative active site motif found in many proteobacteria. Expression of the antitoxin VapB1 counteracts the activity of VapC1 mutants partially defective for toxicity, indicating that the antitoxin binds these mutant proteins in vivo. These findings identify critical chemical features required for the biological function of VapC toxins and PIN-domain proteins.

Indexed as

Amino Acid SequenceAntitoxinsBacterial ProteinsBacterial ToxinsCatalytic DomainGene ExpressionHaemophilus influenzaeMolecular Sequence DataMutationProtein Structure, TertiaryRibonucleasesSequence AlignmentAntitoxinsBacterial ProteinsBacterial ToxinsRibonucleases

Identifiers

PMID25391136
PMCPMC4229260
OpenAlexW1973253284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.